HER-2 positivity is a high risk of recurrence of stage I gastric cancer
Seonhoo Kim, Yeon-Ji Kim, Woo Chul Chung
Korean J Intern Med. 2021;36(6):1327-1337. Published online 2021 Aug 26 DOI: https://doi.org/10.3904/kjim.2020.243
Citations to this article as recorded by 
Clinicopathologic significance of Her-2 and P53 expressions in gastric cancer
Xiaoyu Zhang, Mingchuan Wang, Yizhuo Wang, Xianbin Cheng, Yang Jiang, Huijie Xiao
Asian Journal of Surgery.2023; 46(1): 526. CrossRef
Downregulated Reprimo by LINC00467 participates in the growth and metastasis of gastric cancer
Yuanyuan Wu, Juan Du
Bioengineered.2022; 13(5): 11893. CrossRef
Anti-HER2 scFv-CCL19-IL7 recombinant protein inhibited gastric tumor growth in vivo
Haiqiang Zhang, Xueshuai Ye, Junye Wen, Ziqi Cai, Yang Li, Mengya Zhang, Li Shen, Jianhui Cai
Scientific Reports.2022;[Epub] CrossRef
Tumor Characteristics Associated with Lymph Node Metastasis and Prognosis in Patients with ERBB2-Positive Gastric Cancer
Ran Xu, Yisheng Zhang, Jun Zhao, Ke Chen, Zhengguang Wang, Ashok Pandurangan
Journal of Oncology.2022; 2022: 1. CrossRef